SENZIME AB (SNZZF:OTCMKTS)
$0.39 0.02 (5.4054%)
Analysed SENZIME AB (SNZZF:OTCMKTS) News Sources
Senzime Strengthens U.S. Operations with New Leadership Appointments
29-04-2026
yahoo.com
From Science to Practice: Senzime Obtains FDA 510(k) Clearance for Enhanced TetraGraph System
27-05-2026
yahoo.com
Senzime Advances Sustainable Anesthesia Monitoring with Launch of New EMG Sensor
01-06-2026
yahoo.com
Senzime Strengthens Position in Pediatric Anesthesia by Securing Another Hospital Contract and Highlighting Positive Outcome Data
03-06-2026
yahoo.com
Senzime to Showcase Expanded TetraGraph Capabilities with Launch of TetraAnalytics at Euroanaesthesia 2026
05-06-2026
yahoo.com
Senzime's TetraGraph System Receives ANVISA Regulatory Approval in Brazil
29-06-2026
yahoo.com
Invitation to Presentations of Senzime's Second Quarter 2026 Report
13-07-2026
yahoo.com
Senzime and Philips Medical Systems Enter Development and Commercialization Partnership
15-07-2026
yahoo.com
Interim Report Q2 2026: Strong Sensor Sales and Improved Margins, Despite Continued U.S. Monitor Market Headwinds
16-07-2026
yahoo.com
Senzime Awarded Exclusive 5-Year National Supply Contract with U.S. Veterans Affairs Through Its Partner TrillaMed
05-08-2026
yahoo.com
What is the current price of SENZIME AB (SNZZF:OTCMKTS)?
The current price of SENZIME AB (SNZZF:OTCMKTS) is $0.39.
SENZIME AB (SNZZF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of SENZIME AB (SNZZF:OTCMKTS) since the previous trading day is $0.02.
SENZIME AB (SNZZF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of SENZIME AB (SNZZF:OTCMKTS) since the previous trading day is 5.4054%.
What is the most recent average sentiment score for SENZIME AB (SNZZF:OTCMKTS)?
The most recent average sentiment score for SENZIME AB (SNZZF:OTCMKTS) is 83 out of 100.
What is the most recent average sentiment for SENZIME AB (SNZZF:OTCMKTS)?
The most recent sentiment for SENZIME AB (SNZZF:OTCMKTS) is .
SEC-8K** Filing Available For SENZIME AB (SNZZF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.